Varicella-zoster immunoglobulin (VZIG) 2025

The contract is for the benefit of the Authority and NHS bodies along with any other non-NHS bodies which are necessary for the delivery of services or goods to NHS bodies, local authorities, other government departments or non-departmental public bodies charged with the delivery of healthcare or health related services in the United Kingdom, Crown Dependencies and British Overseas Territories including, without limitation, the National Assembly for Wales, the Northern Ireland Assembly, and Scottish Ministers. The resulting product delivered against the contract may be made available to the UK devolved administrations, Crown Dependencies and British Overseas Territories to undertake their respective immunisation programmes.